187 related articles for article (PubMed ID: 9852194)
1. The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review).
Sack MN; Kelly DP
Int J Mol Med; 1998 Jan; 1(1):17-24. PubMed ID: 9852194
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.
Sack MN; Rader TA; Park S; Bastin J; McCune SA; Kelly DP
Circulation; 1996 Dec; 94(11):2837-42. PubMed ID: 8941110
[TBL] [Abstract][Full Text] [Related]
3. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.
Sack MN; Disch DL; Rockman HA; Kelly DP
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6438-43. PubMed ID: 9177236
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms.
Barger PM; Kelly DP
Am J Med Sci; 1999 Jul; 318(1):36-42. PubMed ID: 10408759
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.
Sack MN; Harrington LS; Jonassen AK; Mjøs OD; Yellon DM
Cardiovasc Drugs Ther; 2000 Feb; 14(1):31-9. PubMed ID: 10755198
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression.
Disch DL; Rader TA; Cresci S; Leone TC; Barger PM; Vega R; Wood PA; Kelly DP
Mol Cell Biol; 1996 Aug; 16(8):4043-51. PubMed ID: 8754802
[TBL] [Abstract][Full Text] [Related]
7. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase.
Kelly DP; Gordon JI; Alpers R; Strauss AW
J Biol Chem; 1989 Nov; 264(32):18921-5. PubMed ID: 2808399
[TBL] [Abstract][Full Text] [Related]
8. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth.
Lehman JJ; Kelly DP
Heart Fail Rev; 2002 Apr; 7(2):175-85. PubMed ID: 11988641
[TBL] [Abstract][Full Text] [Related]
9. Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene.
Ngumbela KC; Sack MN; Essop MF
Mol Cell Biochem; 2003 Aug; 250(1-2):151-8. PubMed ID: 12962153
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation by glucocorticoids of mitochondrial oxidative enzyme genes in the developing rat kidney.
Djouadi F; Bastin J; Kelly DP; Merlet-Benichou C
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):555-62. PubMed ID: 8615829
[TBL] [Abstract][Full Text] [Related]
11. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.
Rosenblatt-Velin N; Montessuit C; Papageorgiou I; Terrand J; Lerch R
Cardiovasc Res; 2001 Dec; 52(3):407-16. PubMed ID: 11738057
[TBL] [Abstract][Full Text] [Related]
12. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure.
Rennison JH; McElfresh TA; Okere IC; Patel HV; Foster AB; Patel KK; Stoll MS; Minkler PE; Fujioka H; Hoit BD; Young ME; Hoppel CL; Chandler MP
Cardiovasc Res; 2008 Jul; 79(2):331-40. PubMed ID: 18339649
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.
Remondino A; Rosenblatt-Velin N; Montessuit C; Tardy I; Papageorgiou I; Dorsaz PA; Jorge-Costa M; Lerch R
J Mol Cell Cardiol; 2000 Nov; 32(11):2025-34. PubMed ID: 11040106
[TBL] [Abstract][Full Text] [Related]
14. Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle.
Cresci S; Wright LD; Spratt JA; Briggs FN; Kelly DP
Am J Physiol; 1996 May; 270(5 Pt 1):C1413-20. PubMed ID: 8967442
[TBL] [Abstract][Full Text] [Related]
15. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
16. Structural organization and regulatory regions of the human medium-chain acyl-CoA dehydrogenase gene.
Zhang ZF; Kelly DP; Kim JJ; Zhou YQ; Ogden ML; Whelan AJ; Strauss AW
Biochemistry; 1992 Jan; 31(1):81-9. PubMed ID: 1731887
[TBL] [Abstract][Full Text] [Related]
17. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.
Lai L; Leone TC; Keller MP; Martin OJ; Broman AT; Nigro J; Kapoor K; Koves TR; Stevens R; Ilkayeva OR; Vega RB; Attie AD; Muoio DM; Kelly DP
Circ Heart Fail; 2014 Nov; 7(6):1022-31. PubMed ID: 25236884
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart.
Lehman JJ; Kelly DP
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):339-45. PubMed ID: 11985547
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
20. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
